All the latest Form happenings. Want to stay in the loop? Subscribe Now
Combined Solution Set Addresses Critical Hurdles in Bringing Gene Therapy Products to IND.
How does the gene therapy field intend to advance so quickly? Enter AI. The scientists at Form Bio are building AI tools that provide an in silico solution to biotech companies and pharma companies working in gene therapy.
Andrew Busey, Co-Founder of Form Bio, shares insights on why vertical AI is poised to revolutionize the cell and gene therapy sector and practical steps to integrate it into development programs.
Explore the transformative impact of AI on drug development and its role in the future of pharmaceutical development.
Form Bio has been recognized by Pharma Manufacturing for its role in expediting gene therapy development. With drugmakers facing incredible pressures to get drugs to market quickly, safely and affordably, every addition to development and manufacturing efficiencies matters.
Chris Haas
May 7, 2024
Discover five simple steps to analyze DNA sequence data and uncover valuable insights effortlessly with point and click Form Bio workflows.
Anusha Sriraman, PhD
April 23, 2024
Explore Form Bio's AI models that predict, optimize, and de-risk AAV vector design outcomes.
Angela Anderson
April 18, 2024
Meet the members of Form Bio’s new Scientific Advisory Board, helping to guide our groundbreaking cell and gene therapy innovation.